Clinical Trial Update: A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the anti-tumor activity and safety of odronextamab in adults with B-cell non-Hodgkin lymphoma who have received prior t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma

Drugs mentioned

• Odronextamab (odronextamab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: B-cell Non-Hodgkin Lymphoma (B-NHL) | Phase 2 | Status: ACTIVE_NOT_RECRUITING